Russell Investments Group
SBBP

Russell Investments Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Russell Investments Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-54,398
Closed -$149K – 3357
2021
Q1 		$149K Sell
54,398
-39,209
-42% -$118K ﹤0.01% 2897
2020
Q4 		$226K Sell
93,607
-134,186
-59% -$323K ﹤0.01% 2727
2020
Q3 		$477K Sell
227,793
-201,299
-47% -$679K ﹤0.01% 2410
2020
Q2 		$1.62M Buy
429,092
+357,859
+502% +$1.07M ﹤0.01% 1763
2020
Q1 		$134K Buy
+71,233
New +$185K ﹤0.01% 2651

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Russell Investments Group's SBBP Position: Q2 2021 in Review

Russell Investments Group sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 54,398 shares — an estimated $149K sold.

Russell Investments Group first reported a position in SBBP in Q1 2020 and held it in 5 quarters. The position peaked at $1.62M in Q2 2020. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Russell Investments Group reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 54,398 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $149K.
  • Russell Investments Group first reported a position in Strongbridge Biopharma plc. in Q1 2020 and held it in 5 quarters.
  • Russell Investments Group's Strongbridge Biopharma plc. position peaked at $1.62M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.